Project Grant HT94252410960
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$366K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Spain
Similar Awards
The Cleveland Clinic Foundation will receive $400,000 from the Defense Health Agency under a two-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2025 to investigate the role of microglia and the NLRP3 inflammasome in contributing to non-motor deficits associated with Parkinson's disease. The Military Medical Research and Development program aims to transform military and public...
The Defense Health Agency awarded a $524,664 Project Grant to the Dana-Farber Cancer Institute, Inc. (DFCI) through the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, which runs from December 1, 2024 to November 30, 2026, will fund research into the "Mechanisms of Irisin-Induced Cognitive Benefit in PD." DFCI, a prestigious non-profit cancer research center in Boston, will leverage its expertise in areas like oncology, immunology, and...
The Defense Health Agency awarded a $199,966 project grant to the Ecole Polytechnique Federale De Lausanne (EPFL) in Switzerland under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will be used to conduct research on the foundations supporting neuroprosthetic management of hypotensive complications in...
The Defense Health Agency awarded a $813,085 Project Grant to the Mayo Clinic Jacksonville (doing business as Scott Lynch MD), a non-profit healthcare and research institution, under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from June 1, 2025 to May 31, 2028, supports advanced biomedical research to resolve the critical role of PINK1 expression and activity in Parkinson's disease pathophysiology and therapeutic intervention. As a prominent medical...
The U.S. Defense Health Agency has awarded a $602,800 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Vlaams Instituut Voor Biotechnologie (VIB), a non-profit research institute in Belgium. The grant, effective September 1, 2024 through August 31, 2027, will fund VIB's research on a "Reduced Combination of Genetic Variants to Predict and Stratify Alzheimer's Disease." This project aims to advance medical solutions for neurodegenerative...
The Department of the Army Medical Command awarded a $751,936 Project Grant to the J. David Gladstone Institutes located in San Francisco, California. The grant period runs from September 26, 2022 through September 25, 2025. The grant supports research into the "Impact of Energy Failure on Alpha-Synuclein Spread and Neurodegeneration" under the Military Medical Research and Development program (CFDA 12.420). This program aims to transform military and public health through innovative...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,186,914 project grant to Mayo Clinic Jacksonville, a nonprofit medical research institution, to resolve the critical role of PINK1 expression and activity in Parkinson's disease pathophysiology and explore therapeutic interventions. The multi-year grant, which runs from June 1, 2025 to May 31, 2028, supports advanced biomedical research aimed at transforming healthcare for military service...
The Defense Health Agency awarded a $998,176 Project Grant to Turun Yliopisto, a Finnish educational institution, to develop new imaging methodology to assess glial cell-driven pathology in multiple sclerosis. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The project has a performance period from September 30, 2024 to...
This federal Project Grant award of $999,999.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research into cell-free DNA epigenetic biomarkers for multiple sclerosis. The award was granted on August 1, 2025 to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution. The project aims to transform healthcare for military service...
The Regents of the University of California, San Francisco (UCSF) has been awarded a $499,985 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a 2-year research project titled "DIET, EXERCISE, AND INFLAMMATION IN EARLY-STAGE NEURONAL ALPHA-SYNUCLEIN DISEASE" to investigate novel approaches for treating neurodegenerative disorders relevant to military personnel and the broader population. As a...